Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemotherapy vs Observation in Infants with Neuroblastoma
NCT00002803Phase 2Completed
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Jul 1995
- Modality
- DNA Intercalators/Alkylators, Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of cyclophosphamide, doxorubicin and vincristine in neuroblastoma (3 arms), sponsored by Cincinnati Children's Hospital Medical Center. Primary endpoints: Incidence of spontaneous regression of localized neuroblastoma and Proportion of infants who do not need chemotherapy. Started Jul 1995; status: completed.
02
Drugs
cyclophosphamidedoxorubicinvincristine
03
Conditions
neuroblastoma
Beyond the preview
Go deeper on NCT00002803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002803.